Name：Evaluation & analysis of medicinal in Chinese
Supervisory unit：China Medical Biotechnology Association
Organizer：China Medical Biotechnology Association & Chongqing University Cancer Hospital
Chairman of the Editorial Board：Du Guanhua
Chairman：Wu Yongzhong
Editor in Chief：Zhang Xianglin
Executive editor：Luo Rui
Publication：China Medicine Biotechnology Press Co., Ltd.
Cycle：Monthly
Address：Beijing
Language：Chinese
Size：16mo
Current Journal
Scan QR code to subscribe
Scan QR code to subscribe
About the Journal
-
Efficacy of Vericiguat in Assisting Conventional Treatment of Chronic Heart Failure and Its Effects on miR-155 and miR-214
History
Author：WANG Xuan、 ZHOU Qiaorui、 MA Guofeng、 JIANG Chong2025-8 -
Statistics and Analysis on Revision of Drug Instructions in China from 2022 to 2025
History
Author：ZHANG Cheng、 LIU Xinyi、QU Liping、 TANG Donglei、 CHEN Wenlin、 SONG Weilin、 CAI Junjie、LI Chenghong、 DONG Xiaonuo、 SHANG Dewei、 DANG Yuanye2025-8
-
Mechanism of Remazolam in Promoting Pyroptosis of Ovarian Cancer Cells by Regulating HMGB1 / TLR4 / NF-κB Pathway
History
Author：YANG Xiaohui、 HAN Yi、 WU Lili2025-8
-
Mechanism of Yixinshu Tablets in the Treatment of Coronary Heart Disease Based on Network Pharmacology and Molecular Docking
History
Author：GUO Meiling、 LI Jiaqi、 ZHAI Yiyan、 JIN Zhengsen、LU Peiying、 LIU Jiangying、 LEI Huiling、 LIU Shuqi、 WU Jiarui2025-8
-
Guidelines for Data Analysis Methods of Safety Evaluation on Post-Marketing Traditional Chinese Medicine
History
Author：ZHANG Xiaomeng、 SUN Xin、 JING Zhiwei、LI Xia、 CAI Yongming、 CHAI Keyan、 ZHANG Junhua、 WU Jiarui2025-8
-
Experts Consensus of Capital Medical University on Full-Process Intervention of Multidisciplinary Diagnosis and Medication Treatment for Mental and Psychological Disorders in Cancer Patients——— Clinical Intervention Section
History
Author：XU Ning、XIAO Gang、 LI Huan、 LI Xingang、 CHENG Kai、 ZHOU Fuchun、LI Bo、 LI Jiqian、 XU Rui、 ZHANG Xinghan、 CHEN Kemou、GUO Xinran、 HUANG Rui、 CHEN Siyu、 PANG Yu、 ZHANG Qing’e2025-8